JP2007522202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007522202A5 JP2007522202A5 JP2006552718A JP2006552718A JP2007522202A5 JP 2007522202 A5 JP2007522202 A5 JP 2007522202A5 JP 2006552718 A JP2006552718 A JP 2006552718A JP 2006552718 A JP2006552718 A JP 2006552718A JP 2007522202 A5 JP2007522202 A5 JP 2007522202A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- combination
- diarrhea
- respect
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 20
- 206010012735 Diarrhoea Diseases 0.000 claims 6
- 230000037396 body weight Effects 0.000 claims 4
- 239000002792 enkephalinase inhibitor Substances 0.000 claims 4
- FELGMEQIXOGIFQ-CYBMUJFWSA-N (3r)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-CYBMUJFWSA-N 0.000 claims 3
- 229940122586 Enkephalinase inhibitor Drugs 0.000 claims 3
- 230000003474 anti-emetic effect Effects 0.000 claims 3
- 239000002111 antiemetic agent Substances 0.000 claims 3
- 229960005343 ondansetron Drugs 0.000 claims 3
- 208000005577 Gastroenteritis Diseases 0.000 claims 2
- 208000012873 acute gastroenteritis Diseases 0.000 claims 2
- MFWNKCLOYSRHCJ-BTTYYORXSA-N granisetron Chemical compound C1=CC=C2C(C(=O)N[C@H]3C[C@H]4CCC[C@@H](C3)N4C)=NN(C)C2=C1 MFWNKCLOYSRHCJ-BTTYYORXSA-N 0.000 claims 2
- 229960003727 granisetron Drugs 0.000 claims 2
- 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 claims 2
- ODUOJXZPIYUATO-UHFFFAOYSA-N 2-[[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]amino]acetic acid (phenylmethyl) ester Chemical group C=1C=CC=CC=1COC(=O)CNC(=O)C(CSC(=O)C)CC1=CC=CC=C1 ODUOJXZPIYUATO-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 206010047700 Vomiting Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 201000009840 acute diarrhea Diseases 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 208000002458 carcinoid tumor Diseases 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 244000045947 parasite Species 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229960002281 racecadotril Drugs 0.000 claims 1
- 108700040249 racecadotril Proteins 0.000 claims 1
- 239000002464 receptor antagonist Substances 0.000 claims 1
- 229940044551 receptor antagonist Drugs 0.000 claims 1
- 230000008673 vomiting Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04290384.9 | 2004-02-12 | ||
| EP04290384A EP1563848A1 (en) | 2004-02-12 | 2004-02-12 | New combinations of an anti-emetic agent and an enkephalinase inhibitor |
| PCT/IB2005/000351 WO2005079850A1 (en) | 2004-02-12 | 2005-02-14 | New combinations of an anti emetic agent and an enkephalinase inhibitor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007522202A JP2007522202A (ja) | 2007-08-09 |
| JP2007522202A5 true JP2007522202A5 (enExample) | 2008-03-13 |
| JP4987487B2 JP4987487B2 (ja) | 2012-07-25 |
Family
ID=34684783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006552718A Expired - Fee Related JP4987487B2 (ja) | 2004-02-12 | 2005-02-14 | 制吐剤及びエンケファリナーゼ阻害物質の新規組み合わせ |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8222294B2 (enExample) |
| EP (2) | EP1563848A1 (enExample) |
| JP (1) | JP4987487B2 (enExample) |
| KR (1) | KR101152308B1 (enExample) |
| CN (1) | CN1917903B (enExample) |
| AT (1) | ATE468138T1 (enExample) |
| AU (1) | AU2005215262B2 (enExample) |
| BR (1) | BRPI0506631B8 (enExample) |
| CA (1) | CA2553827C (enExample) |
| CY (1) | CY1110202T1 (enExample) |
| DE (1) | DE602005021317D1 (enExample) |
| DK (1) | DK1718337T3 (enExample) |
| EA (1) | EA010625B1 (enExample) |
| EC (1) | ECSP066758A (enExample) |
| ES (1) | ES2344909T3 (enExample) |
| HR (1) | HRP20100363T1 (enExample) |
| MA (1) | MA28354A1 (enExample) |
| ME (1) | ME01175B (enExample) |
| NO (1) | NO337320B1 (enExample) |
| NZ (1) | NZ548635A (enExample) |
| PL (1) | PL1718337T3 (enExample) |
| PT (1) | PT1718337E (enExample) |
| RS (1) | RS51329B (enExample) |
| SI (1) | SI1718337T1 (enExample) |
| TN (1) | TNSN06246A1 (enExample) |
| UA (1) | UA88156C2 (enExample) |
| WO (1) | WO2005079850A1 (enExample) |
| ZA (1) | ZA200605872B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2900823B1 (fr) * | 2006-05-15 | 2009-02-13 | Bioprojet Soc Civ Ile | Nouvelle forme d'administration du racecadotril. |
| EP2462922A1 (en) * | 2010-12-10 | 2012-06-13 | Bioprojet | New form of administration of enkephalinase inhibitor |
| EP2866789B1 (en) | 2012-06-28 | 2018-08-01 | Johnson & Johnson Consumer Inc. | Racecadotril lipid compositions |
| US9114171B2 (en) * | 2012-06-28 | 2015-08-25 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
| US9801819B2 (en) * | 2012-06-28 | 2017-10-31 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
| PT2866802T (pt) * | 2012-06-28 | 2016-09-05 | Johnson & Johnson Consumer Inc | Composições líquidas racecadotril |
| MA40859A (fr) | 2014-10-29 | 2017-09-05 | Johnson & Johnson Consumer Inc | Particules de cadotril |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0028575D0 (en) * | 2000-11-23 | 2001-01-10 | Elan Corp Plc | Oral pharmaceutical compositions containing cyclodextrins |
-
2004
- 2004-02-12 EP EP04290384A patent/EP1563848A1/en not_active Withdrawn
-
2005
- 2005-02-14 EP EP05702484A patent/EP1718337B1/en not_active Expired - Lifetime
- 2005-02-14 ME MEP-2010-168A patent/ME01175B/me unknown
- 2005-02-14 EA EA200601466A patent/EA010625B1/ru not_active IP Right Cessation
- 2005-02-14 KR KR1020067016159A patent/KR101152308B1/ko not_active Expired - Fee Related
- 2005-02-14 AT AT05702484T patent/ATE468138T1/de active
- 2005-02-14 WO PCT/IB2005/000351 patent/WO2005079850A1/en not_active Ceased
- 2005-02-14 ES ES05702484T patent/ES2344909T3/es not_active Expired - Lifetime
- 2005-02-14 CN CN2005800046292A patent/CN1917903B/zh not_active Expired - Fee Related
- 2005-02-14 JP JP2006552718A patent/JP4987487B2/ja not_active Expired - Fee Related
- 2005-02-14 US US10/587,899 patent/US8222294B2/en not_active Expired - Fee Related
- 2005-02-14 DE DE602005021317T patent/DE602005021317D1/de not_active Expired - Lifetime
- 2005-02-14 NZ NZ548635A patent/NZ548635A/en not_active IP Right Cessation
- 2005-02-14 HR HR20100363T patent/HRP20100363T1/hr unknown
- 2005-02-14 UA UAA200608901A patent/UA88156C2/ru unknown
- 2005-02-14 DK DK05702484.6T patent/DK1718337T3/da active
- 2005-02-14 RS RSP-2010/0286A patent/RS51329B/sr unknown
- 2005-02-14 BR BRPI0506631A patent/BRPI0506631B8/pt not_active IP Right Cessation
- 2005-02-14 PL PL05702484T patent/PL1718337T3/pl unknown
- 2005-02-14 SI SI200531056T patent/SI1718337T1/sl unknown
- 2005-02-14 AU AU2005215262A patent/AU2005215262B2/en not_active Ceased
- 2005-02-14 PT PT05702484T patent/PT1718337E/pt unknown
- 2005-02-14 CA CA2553827A patent/CA2553827C/en not_active Expired - Fee Related
-
2006
- 2006-07-17 ZA ZA2006/05872A patent/ZA200605872B/en unknown
- 2006-08-03 TN TNP2006000246A patent/TNSN06246A1/fr unknown
- 2006-08-08 EC EC2006006758A patent/ECSP066758A/es unknown
- 2006-08-10 MA MA29256A patent/MA28354A1/fr unknown
- 2006-09-05 NO NO20063973A patent/NO337320B1/no not_active IP Right Cessation
-
2010
- 2010-07-09 CY CY20101100645T patent/CY1110202T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009525343A5 (enExample) | ||
| NZ605888A (en) | Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain | |
| JP2013511507A5 (enExample) | ||
| CN103096881B (zh) | 含有具有不愉快味道的药物的膜制剂 | |
| JP2015515475A5 (enExample) | ||
| JP2010522137A5 (enExample) | ||
| ES2791710T3 (es) | Nueva forma de administración de racecadotrilo | |
| RU2010147287A (ru) | Комбинированная композиция | |
| WO2010103544A3 (en) | A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants | |
| NO20030897D0 (no) | Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer | |
| SI2729130T1 (en) | Combined formulations of darunavir | |
| JP4632204B2 (ja) | 下痢型過敏性腸症候群治療剤 | |
| EP4442321A3 (en) | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor | |
| RU2007107368A (ru) | Композиция, содержащая десмопрессин | |
| HRP20201152T1 (hr) | Kondenzirani benzazepin za liječenje mucanja | |
| JP2011500589A5 (enExample) | ||
| JP2006508977A5 (enExample) | ||
| JP2008533022A5 (enExample) | ||
| HUP0203148A2 (hu) | Mirtazapint tartalmazó orálisan dezintegrálódó készítmény | |
| MA32722B1 (fr) | Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion | |
| HRP20100363T1 (hr) | Nove kombinacije antagonista receptora 5-ht3 s racekatodrilom ili deksekatodrilom | |
| WO2004037228A8 (en) | Sustained release compositions containing alfuzosin | |
| WO2006053089A3 (en) | Methods and formulations for making pharmaceutical compositions containing bupropion | |
| ES2367896T3 (es) | Agente para el tratamiento del sindrome del colon irritable con predominio de diarrea. | |
| RU2011113733A (ru) | Производные 1-амино-алкилциклогексана для лечения когнитивного нарушения при шуме в ушах |